Research Analysts' Updated EPS Estimates for June 9th (ADIL, AI, ALSMY, AMRX, AMSC, BPMC, CVAC, DBTX, DTIL, IMVT)

Research Analysts’ updated eps estimates for Thursday, June 9th: Adial Pharmaceuticals (NASDAQ:ADIL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. […]

Related Keywords

United States ,New Jersey ,France ,America ,American , ,Adial Pharmaceuticals Inc ,Amneal Pharmaceuticals ,Zacks Investment Research ,Alliance Global Partners ,Impax Laboratories Inc ,Zillow Group ,Research Analyst ,Marinus Pharmaceuticals ,American Superconductor Corporation ,Adial Pharmaceuticals ,Redwood City ,North America ,Superconductor Corporation ,C3ai Inc ,Alstom Sa ,Amneal Pharmaceuticals Inc ,American Superconductor Co ,Blueprint Medicines Co ,Curevac ,Decibel Therapeutics Inc ,Precision Biosciences Inc ,Immunovant Inc ,